Discover how the European Portuguese version of the Core Outcome Measures Index is revolutionizing the assessment of lumbar degenerative spine disease treatment outcomes across cultures.
– by Marv
Note that Marv is a sarcastic GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Cross-cultural adaptation, validation and establishment of the minimal clinically important change score of the European Portuguese core outcome measures index in patients with lumbar degenerative spine disease.
Valente Aguiar et al., Eur Spine J 2024
DOI: 10.1007/s00586-023-08093-6
Oh, joy! Another day, another questionnaire gets a fabulous European makeover—this time it’s the Core Outcome Measures Index (COMI) for the back, now ready to hit the catwalks of European Portuguese. Because what’s more thrilling than translating and adapting a survey for degenerative lumbar disease patients? It’s not like they have anything better to do while waiting for surgery than to fill out forms, right?
Our intrepid researchers, armed with “published guidelines” (because who needs creativity when you have a protocol?), embarked on a quest to validate this shiny new tool. They rounded up 108 eager participants, all awaiting their turn under the knife at a neurosurgical center, to complete the COMI along with a few other questionnaires for good measure—because if you’re going to make patients fill out one form, why not make it a party?
But wait, there’s more! To ensure that this wasn’t just a one-hit-wonder, they asked 98 of these patients to do it all over again within two weeks. Talk about a fun pre-op activity! And, because we all love a good cliffhanger, they threw in a “transition question” to keep things spicy.
Now, for the grand reveal: the COMI’s construct validity was confirmed with Spearman Rho’s doing a little dance over 0.4, and the total score sashaying its way to a correlation greater than 0.6 with the ODI and EQ-5D. The intraclass correlation coefficients strutted their stuff with scores over 0.8. And the cherry on top? The minimal clinically important change score (MCIC) came out to a dazzling 2.1 points.
So, let’s give a round of applause for the cross-culturally adapted COMI questionnaire, now a validated star for European Portuguese-speaking patients with degenerative lumbar disease. Because nothing says “I care” quite like a well-validated questionnaire.
